User profiles for C Beedham

Catherine Needham

Verified email at bham.ac.uk
Cited by 4435

Human liver aldehyde oxidase: inhibition by 239 drugs

…, P Huynh, MC Allen, C Beedham - The Journal of Clinical …, 2004 - Wiley Online Library
The authors tested 239 frequently used drugs and other compounds for their potential to
inhibit the drug‐metabolizing enzyme, aldehyde oxidase, in human liver cytosol. A sensitive, …

Ziprasidone metabolism, aldehyde oxidase, and clinical implications

C Beedham, JJ Miceli, RS Obach - Journal of clinical …, 2003 - journals.lww.com
… clinical dose of ziprasidone (160 mg/day) under steady-state conditions, introduction of
ketoconazole at 400 mg/day produced a 39% increase in exposure at the estimated time of C

Molybdenum hydroxylases as drug-metabolizing enzymes

C Beedham - Drug metabolism reviews, 1985 - Taylor & Francis
… However, in vitro a number of other compounds such as potassium ferricyanide, cytochrome
c , and dichlorophenolindophenol can replace oxygen in its role as an electron acceptor [ 15…

In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver

MR Rashidi, JA Smith, SE Clarke, C Beedham - Drug Metabolism and …, 1997 - ASPET
… 10 μM leupeptin at 4C and homogenized at 12,000 rpm for 1–2 min, using a Ystral X10/25
homogenizer at 4C. The resulting homogenate was then heated at 55–57C for 10 min on a …

Species variation in hepatic aldehyde oxidase activity

C Beedham, SE Bruce, DJ Critchley, Y Al-Tayib… - European journal of …, 1987 - Springer
The activity of hepatic aldehyde oxidase from rabbit, guinea pig, rat, marmoset, dog, baboon
and man was investigated in vitro with charged and uncharged N-heterocyclic substrates: K …

3 Molybdenum Hydroxylases: Biological Distribution and Substrate-Inhibitor Specificity

C Beedham - Progress in medicinal chemistry, 1987 - Elsevier
Publisher Summary This chapter discusses the biological distribution and substrate-inhibitor
specificity of molybdenum hydroxylases. Aldehyde oxidase and xanthine oxidase are …

The role of non—P450 enzymes in drug oxidation.

C Beedham - Pharmacy World and Science, 1997 - Springer
… Both N-oxides can be reduced back to nicotine by tissue reductases such as cytochrome
P450, NADPH-cytochrome (c) reductase and xanthine oxidase and/or gut flora [9] and can thus …

Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit …

C Beedham, DJP Critchley, DJ Rance - Archives of Biochemistry and …, 1995 - Elsevier
… Initial oxidation rates for at least seven concentrations of substrate were measured at 37C
and pH 7 and kinetic constants (K„, K, and V, values) were calculated as previously described …

Realising the potential of co-production: Negotiating improvements in public services

C Needham - Social policy and society, 2008 - cambridge.org
The concept of co-production – also called co-creation – is gaining widespread attention as
a way to increase user involvement in service provision in the UK. It is usually taken as self-…

[HTML][HTML] A primer on learning in Bayesian networks for computational biology

CJ Needham, JR Bradford, AJ Bulpitt… - PLoS computational …, 2007 - journals.plos.org
… The prior is B(7,3), indicating prior knowledge that high conservation is found in interaction
sites; it corresponds to adding seven pseudocounts to the C = high category, and three to C = …